BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4003420)

  • 21. Recycled unused piggyback admixtures through the use of tamper-proof safety caps.
    Jennings RH; Schad RF; Kaurich J
    Hosp Pharm; 1982 Dec; 17(12):643-5, 652. PubMed ID: 10257924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new batch method of preparing intravenous piggyback solutions in polyvinylchloride containers.
    Levy R; Kleinberg M; Lee P
    Hosp Pharm; 1980 Oct; 15(10):504-6. PubMed ID: 10309298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost comparison of oral, nasogastric, and intramuscular cimetidine drug delivery systems.
    Lau NC; Caldwell RD; Arford PH
    Hosp Pharm; 1992 Nov; 27(11):946-7, 950-2, 954-6 passim. PubMed ID: 10122039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of drug distribution costs for controlled versus noncontrolled oral analgesics.
    Reynolds RC; Ploetz P; Thielke TS
    Am J Hosp Pharm; 1984 Aug; 41(8):1558-63. PubMed ID: 6475974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The case for the heparin flush.
    Cyganski JM; Donahue JM; Heaton JS
    Am J Nurs; 1987 Jun; 87(6):796-7. PubMed ID: 3647723
    [No Abstract]   [Full Text] [Related]  

  • 26. Nitroglycerin injection manufactured by a hospital pharmacy.
    Clarke AJ; Watkins RE
    Am J Hosp Pharm; 1985 Jul; 42(7):1542-6. PubMed ID: 3927720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cost-benefit analysis of a semi-automated process in the preparation of unit-doses by the Pharmacy Department].
    Poveda Andrés JL; Hernández Sansalvador M; Díez Martínez AM; García Gómez C
    Farm Hosp; 2004; 28(2):76-83. PubMed ID: 15101798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacy services: I. Time and cost study in a medical center hospital.
    Schwartz JI; Swanson LN
    Hosp Formul; 1975 Dec; 10(12):582-4. PubMed ID: 10237824
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost of developing a computerized drug file.
    Strand LM; Cipolle RJ; Zaske DE
    Am J Hosp Pharm; 1981 Sep; 38(9):1334-6. PubMed ID: 7282718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. More efficient system for preparing total parenteral nutrient solutions.
    Condella F; Baptista RJ; Griffin RE
    Am J Hosp Pharm; 1983 Dec; 40(12):2146-9. PubMed ID: 6419587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost of implementing and maintaining a hospital-pharmacy-based online literature search system.
    Souney PF; Churchill WW; Kaul AF
    Am J Hosp Pharm; 1985 Nov; 42(11):2496-8. PubMed ID: 4073067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indicators to control drug costs in hospitals.
    Mehl B
    Am J Hosp Pharm; 1984 Apr; 41(4):667-75. PubMed ID: 6720708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two methods for allocating pharmacy cost per patient case.
    Pink GH; Bolley HB; Cockerill RW
    Am J Hosp Pharm; 1994 May; 51(10):1331-4. PubMed ID: 8085571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reducing waste: a significant cost containment measure in an i.v. additive program.
    Coppola PA; Cassidy AP
    Hosp Pharm; 1987 Dec; 22(12):1215-6, 1246. PubMed ID: 10285376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of repackaging labetalol hydrochloride injection for intraoperative use.
    Gill DL; Knudsen AK
    Am J Hosp Pharm; 1988 Dec; 45(12):2528-9. PubMed ID: 3147595
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
    Capers CC; Bess DT; Branam AC; Falbe WJ; Mrochek SA; Haymond JD; Stahl AA
    Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost comparison of seven antibiotic combinations as empiric therapy in a simulated febrile neutropenic patient.
    Parr MD; Waite WW; Hansen LA; McDaniel PA
    Am J Hosp Pharm; 1985 Nov; 42(11):2484-8. PubMed ID: 4073066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect on drug costs of implementing decentralized drug distribution.
    Roberts AW
    Am J Hosp Pharm; 1983 Apr; 40(4):604-6. PubMed ID: 6846367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlling moxalactam and cefotaxime use with a target drug program.
    Abramowitz PW; Ludwig DJ; Mansur JM; Nold EG
    Hosp Pharm; 1983 Aug; 18(8):416-20. PubMed ID: 10261791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of an acceptance sampling plan for post-production quality control of chemotherapeutic batches in an hospital pharmacy.
    Borget I; Laville I; Paci A; Michiels S; Mercier L; Desmaris RP; Bourget P
    Eur J Pharm Biopharm; 2006 Aug; 64(1):92-8. PubMed ID: 16750352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.